Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
2.980
-0.180 (-5.70%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $736.57 million as of July 2, 2024. Its market cap has increased by 91.27% in one year.
Market Cap
736.57M
Enterprise Value
143.13M
1-Year Change
91.27%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since July 1, 2020, Nuvation Bio's market cap has increased from $181.60M to $736.57M, an increase of 305.60%. That is a compound annual growth rate of 41.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 781.10M | 136.27% |
| Dec 29, 2023 | 330.60M | -21.15% |
| Dec 30, 2022 | 419.30M | -77.35% |
| Dec 31, 2021 | 1.85B | 757.43% |
| Dec 31, 2020 | 215.90M | 18.89% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 739.23M |
| Harrow Health | 739.13M |
| Mesoblast | 738.93M |
| Cytek Biosciences | 732.50M |
| Immunome | 725.62M |
| Embecta | 720.88M |
| HilleVax | 718.96M |
| Praxis Precision Medicines | 707.58M |